Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience

Hepatoblastoma

Evaluation of Lung Metastases Based on Ultrashort Echo Time MRI GastroIntestinal Cancer in Children and Adolescents Relapsed and Refractory Hepatoblastoma: A Prospective Registry and Liver Tumor Research Consortium Initiative Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy Deep Learning Magnetic Resonance Imaging Radiomics for Diagnostic Value of Hepatic Tumors in Infants ET140203 T-Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma Biomarkers in Tissue Samples From Young Patients With Liver Cancer Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer Paediatric Hepatic International Tumour Trial Diagnostic Accuracy of PIVKA-II Combining With Alpha-Fetoprotein in Hepatic Tumor T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR) Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery Hepatoblastoma Biology Study and Tissue Bank Combined Modality Therapy in Hepatoblastoma: South Egypt Cancer Institute Experience